FTC Allows J&J To Buy Pfizer Unit If It Sells 4 Brands

Law360, New York (December 13, 2006, 12:00 AM EST) -- A day after Johnson & Johnson secured approval from the European Union to continue its acquisition of Pfizer Inc.’s Consumer Healthcare unit, the companies agreed to sell more businesses in the United States to appease the Federal Trade Commission.

J&J first announced that it would acquire Pfizer Consumer Healthcare for $16.6 billion in June, saying the deal would create the world’s premier consumer health care company.

“This acquisition builds upon our broad base in health care products and our leadership objectives in the consumer, pharmaceutical and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.